vir combination (43742-2123)

Drug Facts

Product Profile

Brand Name vir combination

Generic Name adenoviren nosode, cytomegalovirus nosode, herpes simplex virus 1 dna, herpes simplex virus 2 dna, epstein-barr virus nosode, hepatitis b nosode, herpes simplex 1 nosode, herpes simplex 2 nosode, human herpesvirus 6a, human herpesvirus 6b, influenzinum (2022-2023)

Labeler deseret biologicals, inc.

Dosage Form LIQUID

Routes

ORAL

Active Ingredients

hepatitis b virus 33 [hp_X]/mL, human adenovirus e serotype 4 strain cl-68578 antigen 12 [hp_C]/mL, human herpesvirus 1 12 [hp_X]/mL, human herpesvirus 2 12 [hp_X]/mL, human herpesvirus 4 16 [hp_C]/mL, human herpesvirus 5 18 [hp_X]/mL, human herpesvirus 6 15 [hp_X]/mL, influenza a virus a/darwin/9/2021 ivr-228 (h3n2) antigen (uv, formaldehyde inactivated) 12 [hp_X]/mL, influenza a virus a/victoria/2570/2019 ivr-215 (h1n1) antigen (uv, formaldehyde inactivated) 12 [hp_X]/mL, influenza b virus b/austria/1359417/2021 bvr-26 antigen (uv, formaldehyde inactivated) 12 [hp_X]/mL, influenza b virus b/phuket/3073/2013 antigen (uv, formaldehyde inactivated) 12 [hp_X]/mL

Manufacturer

Deseret Biologicals, Inc.

Identifiers & Regulatory

Product NDC 43742-2123

Product ID 43742-2123_6bd4d4d1-1647-41de-a1bc-432a1d627106

Product Type HUMAN OTC DRUG

Marketing Category UNAPPROVED HOMEOPATHIC

Marketing Start 2024-01-25

Marketing End 2029-03-20

Pharmacologic Class

Classes

actively acquired immunity [pe] live human adenovirus type 4 vaccine [epc] vaccines adenovirus [chemical/ingredient] live unattenuated [chemical/ingredient]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 437422123

Hyphenated Format 43742-2123

Supplemental Identifiers

UPC

0810151884202

UNII

77H9EM77P7 FKD3DUK39I 22G38P19RL 74J6DNH49U 2A26YW7PNX 7COI029E6K 4IX4VP35CR P483J7GX6D 34C49NV47P TBV2PPG6EF H2198F8ZNA

Packaging Origin

Original Packager

true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name vir combination (source: ndc)

Generic Name adenoviren nosode, cytomegalovirus nosode, herpes simplex virus 1 dna, herpes simplex virus 2 dna, epstein-barr virus nosode, hepatitis b nosode, herpes simplex 1 nosode, herpes simplex 2 nosode, human herpesvirus 6a, human herpesvirus 6b, influenzinum (2022-2023) (source: ndc)

Routes

ORAL

source: ndc

Resolved Composition

Strengths

33 [hp_X]/mL
12 [hp_C]/mL
12 [hp_X]/mL
16 [hp_C]/mL
18 [hp_X]/mL
15 [hp_X]/mL

source: ndc

Packaging

30 mL in 1 BOTTLE, DROPPER (43742-2123-1)

source: ndc

Packages (1)

43742-2123-1 30 mL in 1 BOTTLE, DROPPER (43742-2123-1)

Ingredients (11)

hepatitis b virus (33 [hp_X]/mL) human adenovirus e serotype 4 strain cl-68578 antigen (12 [hp_C]/mL) human herpesvirus 1 (12 [hp_X]/mL) human herpesvirus 2 (12 [hp_X]/mL) human herpesvirus 4 (16 [hp_C]/mL) human herpesvirus 5 (18 [hp_X]/mL) human herpesvirus 6 (15 [hp_X]/mL) influenza a virus a/darwin/9/2021 ivr-228 (h3n2) antigen (uv, formaldehyde inactivated) (12 [hp_X]/mL) influenza a virus a/victoria/2570/2019 ivr-215 (h1n1) antigen (uv, formaldehyde inactivated) (12 [hp_X]/mL) influenza b virus b/austria/1359417/2021 bvr-26 antigen (uv, formaldehyde inactivated) (12 [hp_X]/mL) influenza b virus b/phuket/3073/2013 antigen (uv, formaldehyde inactivated) (12 [hp_X]/mL)

Linked Drug Pages (1)

Vir Combination ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload

{"route": ["ORAL"], "spl_id": "6bd4d4d1-1647-41de-a1bc-432a1d627106", "openfda": {"upc": ["0810151884202"], "unii": ["77H9EM77P7", "FKD3DUK39I", "22G38P19RL", "74J6DNH49U", "2A26YW7PNX", "7COI029E6K", "4IX4VP35CR", "P483J7GX6D", "34C49NV47P", "TBV2PPG6EF", "H2198F8ZNA"], "spl_set_id": ["382d5062-5da5-4fd9-a39b-367ff9d88d87"], "manufacturer_name": ["Deseret Biologicals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 mL in 1 BOTTLE, DROPPER (43742-2123-1)", "package_ndc": "43742-2123-1", "marketing_end_date": "20290320", "marketing_start_date": "20240125"}], "brand_name": "Vir Combination", "product_id": "43742-2123_6bd4d4d1-1647-41de-a1bc-432a1d627106", "dosage_form": "LIQUID", "pharm_class": ["Actively Acquired Immunity [PE]", "Live Human Adenovirus Type 4 Vaccine [EPC]", "Vaccines", "Adenovirus [Chemical/Ingredient]", "Vaccines", "Live", "Unattenuated [Chemical/Ingredient]"], "product_ndc": "43742-2123", "generic_name": "Adenoviren Nosode, Cytomegalovirus Nosode, Herpes Simplex Virus 1 DNA, Herpes Simplex Virus 2 DNA, Epstein-Barr Virus Nosode, Hepatitis B Nosode, Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Human Herpesvirus 6A, Human Herpesvirus 6B, Influenzinum (2022-2023)", "labeler_name": "Deseret Biologicals, Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Vir Combination", "active_ingredients": [{"name": "HEPATITIS B VIRUS", "strength": "33 [hp_X]/mL"}, {"name": "HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN", "strength": "12 [hp_C]/mL"}, {"name": "HUMAN HERPESVIRUS 1", "strength": "12 [hp_X]/mL"}, {"name": "HUMAN HERPESVIRUS 2", "strength": "12 [hp_X]/mL"}, {"name": "HUMAN HERPESVIRUS 4", "strength": "16 [hp_C]/mL"}, {"name": "HUMAN HERPESVIRUS 5", "strength": "18 [hp_X]/mL"}, {"name": "HUMAN HERPESVIRUS 6", "strength": "15 [hp_X]/mL"}, {"name": "INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED)", "strength": "12 [hp_X]/mL"}, {"name": "INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED)", "strength": "12 [hp_X]/mL"}, {"name": "INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (UV, FORMALDEHYDE INACTIVATED)", "strength": "12 [hp_X]/mL"}, {"name": "INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED)", "strength": "12 [hp_X]/mL"}], "marketing_category": "UNAPPROVED HOMEOPATHIC", "marketing_end_date": "20290320", "marketing_start_date": "20240125"}